Provultra plus
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80021675
- Status
- Inactive licence
- Licence date
- 8 October 2010
- Revision date
- 15 June 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Saccharomyces boulardii lyo Source : I-3799 | 1.25 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Gélatine, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | Not specified |
Uses authorised in Canada
Probiotique bénéfique pour la santé et/ou exerçant un effet bénéfique sur la santé. Fournit des micro-organismes vivants qui sont bénéfique pour la santé et/ou exerçant un effet bénéfique sur la santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Cesser l'utilisation et consulter un praticien de soins de santé si des symptômes de trouble digestifs (e.g. diarrhée) se manifestent, s'aggravent ou persistent au-delà 3 jours.
- Contre-indications
Ne pas utiliser si vous souffrez de nausées, de la fièvre, de vomissement, de diarrhée sanglante ou de douleurs abdominales intenses. Ne pas utiliser si vous souffrez d'un déficit immunitaire (e.g. sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes).
Source
Official Health Canada record, licence 80021675
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging